UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063022
Receipt number R000072144
Scientific Title Impact of deep learning reconstruction on apparent diffusion coefficient values and image quality in pelvic diffusion-weighted MRI: a prospective observational study
Date of disclosure of the study information 2026/09/22
Last modified on 2026/09/22 20:41:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of AI-based image reconstruction on quantitative values (ADC) and image quality in diffusion-weighted MRI

Acronym

DLR-ADC study in pelvic DWI

Scientific Title

Impact of deep learning reconstruction on apparent diffusion coefficient values and image quality in pelvic diffusion-weighted MRI: a prospective observational study

Scientific Title:Acronym

DLR-ADC study in pelvic DWI

Region

Japan


Condition

Condition

Gynecological diseases (endometrial cancer, cervical cancer, ovarian cancer, etc.)

Classification by specialty

Obstetrics and Gynecology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To compare ADC values and image-quality metrics between conventional reconstruction and multiple acquisition and reconstruction conditions of pelvic diffusion-weighted imaging obtained within the same examination. The aims are to identify the range of conditions in which ADC values remain equivalent to conventional reconstruction, and to determine whether classification based on an established diagnostic cutoff of 0.9 x 10-3 mm2/s changes across reconstruction conditions.

Basic objectives2

Others

Basic objectives -Others

Evaluation of the effect of image reconstruction conditions on apparent diffusion coefficient values and image-quality metrics derived from diffusion-weighted imaging

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Difference in tumor ADC between each acquisition and reconstruction condition and the conventional reconstruction of each scanner, assessed against an equivalence margin of +/-0.05 x 10-3 mm2/s.

Key secondary outcomes

- Reclassification rate across conditions based on the ADC cutoff of 0.9 x 10-3 mm2/s
- Dose-response relationship between denoising level and ADC change, by tissue type
- ADC histogram metrics (10th percentile, standard deviation) across conditions
- ADC measured with a small region of interest placed on the visually lowest-signal area
- Signal intensity ratio, signal-to-noise ratio, and contrast-to-noise ratio, measured on both ADC maps and high b-value diffusion-weighted images
- ADC changes by tissue type (tumor, myometrium, skeletal muscle, and normal endometrium or coexisting leiomyoma when measurable)
- Comparison of ADC values and image quality between acquisition methods (single-shot echo-planar imaging, compressed sensing, and others)
- Three-point qualitative assessment of lesion-to-background separation by three readers, on both ADC maps and high b-value images


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

(1) Patients who underwent pelvic MRI on a 1.5-T or 3-T scanner at our institution for the workup of gynecological disease between study approval and March 2028. The standard clinical protocol includes diffusion-weighted imaging with multiple acquisition and reconstruction conditions. (2) Age 18 years or older. (3) Reconstruction data available for analysis.

Key exclusion criteria

Image quality judged inadequate for quantitative analysis because of severe motion or other causes.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name TSUKASA
Middle name
Last name SAIDA

Organization

University of Tsukuba

Division name

Institute of Medicine, Department of Diagnostic Radiology and IVR

Zip code

305-8575

Address

1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan

TEL

029-853-3205

Email

saida_sasaki_tsukasa@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name TSUKASA
Middle name
Last name SAIDA

Organization

University of Tsukuba

Division name

Institute of Medicine, Department of Diagnostic Radiology and IVR

Zip code

305-8575

Address

1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan

TEL

029-853-3205

Homepage URL


Email

saida_sasaki_tsukasa@md.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

University of Tsukuba

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board, University of Tsukuba Hospital

Address

2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, Japan

Tel

029-853-3749

Email

rinshokenkyu@un.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

筑波大学附属病院


Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 08 Month 15 Day

Date of IRB


Anticipated trial start date

2026 Year 10 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study design: A single-center prospective observational study. Consecutive patients imaged for clinical purposes after study approval are enrolled. No intervention is performed.

Recruitment: All consecutive patients who meet the inclusion criteria and undergo pelvic MRI on a 1.5-T or 3-T scanner at our institution for the workup of gynecological disease between study approval and March 2028. No volunteers are recruited. Consent is obtained through an opt-out procedure.

Recruitment period: From study approval to March 2028.

Measurements: Diffusion-weighted images acquired under the standard clinical protocol with multiple acquisition and reconstruction conditions are analyzed. Regions of interest are placed on the tumor and on reference tissues, including myometrium, skeletal muscle, and, when measurable, normal endometrium and coexisting leiomyoma. Mean, standard deviation, 10th percentile, and signal intensity are measured on both ADC maps and high b-value images. Signal intensity ratio, signal-to-noise ratio, and contrast-to-noise ratio are calculated. Three readers also perform a three-point qualitative assessment of lesion-to-background separation. Regions of interest are placed on the reference images and copied to all reconstruction conditions at identical coordinates.

Analysis: A mixed effects model with patient as a random effect is used to estimate the difference in ADC between each condition and the conventional reconstruction, with 95% confidence intervals, which are compared with a prespecified equivalence margin of +/-0.05 x 10-3 mm2/s. Dunnett-type multiple comparison is applied. Descriptive statistics are reported as median and interquartile range.


Management information

Registered date

2026 Year 09 Month 22 Day

Last modified on

2026 Year 09 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072144